UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000047323
Receipt number R000053976
Scientific Title Effects of repetitive peripheral magnetic sitmulation on motor recovery of paretic upper extremity after stroke
Date of disclosure of the study information 2022/03/30
Last modified on 2022/03/30 13:46:52

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Neurorehabilitation of paretic upper extremity after stroke
using rPMS

Acronym

Neurorehabilitation of stroke using rPMS

Scientific Title

Effects of repetitive peripheral magnetic
sitmulation on motor recovery of paretic upper extremity
after stroke

Scientific Title:Acronym

Effects of rPMS on UE function after stroke

Region

Japan


Condition

Condition

stroke

Classification by specialty

Rehabilitation medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

to investigate the effects of rPMS on paretic UE function after stroke

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Fugl-Meyer assessment of upper extremities (FMA)
was estimated at baseline, 1 week after , and 2 week after intervention.

Key secondary outcomes

Wolf motor function test
Box and Block test
Manual function test (MFT)
SIAS(stroke impairment assessment set)
grip power
Each measure was estimated at baseline, 1 week after , and 2 week after intervention.


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification

YES

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

rPMS preconditioning prior to standard care of 40 minutes for 10 days

Interventions/Control_2

standard care of 40 minutes for 10 days

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

90 years-old >

Gender

Male and Female

Key inclusion criteria

(1) medically stable; (2) hospitalized adults within two weeks of stroke; (3) age 20 to 89 years; (4) intact skin on the hemiparetic arm; (5) adequate cognition to participate; (6) first-ever, severe UE paresis (stroke impairment assessment set (SIAS): knee-mouth test ranging 1 to 3; finger function test 1a to 3).

Key exclusion criteria

(1) past history of stroke or brain injury or brain tumor; (2) metal implant in the head or within the stimulation area; (3) dysphasia; (4) history of cardiac arrhythmia with hemodynamic instability; (5) comorbidity with neurodegenerative diseases and mental disorders; (6) uncontrolled seizure disorder; (7) disturbed consciousness; (8) implanted stimulator (such as cardiac pacemaker); (9) pregnancy

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Shigeru
Middle name
Last name Obayashi

Organization

Dokkyo medical University, Saitama medical center

Division name

Department of rehabilitation medicine

Zip code

343-8555

Address

2-1-50 minami-Koshigaya Koshigaya city, Saitama, JAPAN

TEL

048-965-1111

Email

ohbayash@dokkyomed.ac.jp


Public contact

Name of contact person

1st name Shigeru
Middle name
Last name Obayashi

Organization

Dokkyo medical University, Saitama medical center

Division name

Department of rehabilitation medicine

Zip code

343-8555

Address

2-1-50 minami-Koshigaya Koshigaya city, Saitama, JAPAN

TEL

048-965-1111

Homepage URL


Email

ohbayash@dokkyomed.ac.jp


Sponsor or person

Institute

Dokkyo medical University

Institute

Department

Personal name



Funding Source

Organization

Grants-in-Aid for Scientific Research, Japan Society for the Promotion of Science (JSPS)

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Dokkyo medical University, Saitama medical center, IRB section

Address

2-1-50 minami-Koshigaya Koshigaya city, Saitama, JAPAN

Tel

048-965-0658

Email

k-shien@dokkyomed.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 03 Month 30 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications

https://doi.org/10.3233/NRE-203085

Number of participants that the trial has enrolled

19

Results

The present study suggested the beneficial effect of rPMS for severe UE paresis during early acute phase of stroke.
This is the first report describing beneficial effects of rPMS on severe UE dysfunction during early acute phase of stroke when applying rPMS to the whole UE. These findings would contribute to the justification for specific treatment parameters to maximize severe UE recovery after stroke.

Results date posted

2022 Year 03 Month 30 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results

2020 Year 03 Month 01 Day

Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Main results already published

Date of protocol fixation

2019 Year 02 Month 01 Day

Date of IRB

2019 Year 02 Month 01 Day

Anticipated trial start date

2019 Year 02 Month 01 Day

Last follow-up date

2021 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2022 Year 03 Month 30 Day

Last modified on

2022 Year 03 Month 30 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000053976